Nick Poulios has been named CEO of San Francisco-based Brain Health Therapeutics. Poulios was most recently head of medical outcomes, reimbursement, and economics at Roche Molecular Diagnostics. Brain Health is developing treatments for neurological disorders using new formulations and combinations of previously approved drugs.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
